🚨 DR. WILLIAM MAKIS SAYS THIS IS THE MOST IMPORTANT IVERMECTIN DOSING GRAPH HE'S CREATED.
Not a new chemotherapy drug.
Not a breakthrough immunotherapy.
Not a billion-dollar cancer treatment.
Just one simple dosing strategy.
According to Dr. William Makis, this is the dosing framework he believes everyone researching repurposed medicines for cancer should understand first.
And it all starts with one number.
📌 1 mg/kg/day.
Before explaining why, here's the dosing framework Dr. Makis discusses.
📊 The Four Ivermectin Dosing Ranges
🟢 Low Dose: ≤0.5 mg/kg/day
Used for cancers in remission, strong family history, genetic predisposition, prophylaxis, and lower-dose protocols discussed in published case reports.
🟡 Medium Dose: 1.0 mg/kg/day
Dr. Makis' recommended starting dose for most cancers.
🔵 High Dose: 2.0 mg/kg/day
Discussed for very aggressive cancers, including leukaemia, pancreatic cancer, and some brain cancers.
🔴 Very High Dose: ≥2.5 mg/kg/day
Discussed in selected reported cases involving extensive metastatic disease or extremely poor prognosis, where temporary visual side effects have also been reported.
Now here's why Dr. Makis believes 1 mg/kg/day deserves the most attention.
After reviewing laboratory research, published studies, and numerous case reports, he says this is the starting dose he recommends for most cancers.
According to Dr. Makis, research has investigated Ivermectin across a surprisingly wide range of cancers, including:
• Breast cancer
• Colon cancer
• Lung cancer
• Pancreatic cancer
• Kidney (renal cell) cancer
• Gastric cancer
• Leukemia
One exception stood out.
Lymphoma.
Dr. Makis says he has found very little published research involving Ivermectin and lymphoma.
That doesn't mean it doesn't work.
It simply means the evidence is currently limited.
❓What does 1 mg/kg/day actually look like?
For someone weighing 60 kg (132 lbs)...
That's approximately 60 mg of Ivermectin every day.
Equivalent to:
💊 Five 12 mg tablets
OR
💧 About 6 mL of liquid Ivermectin, roughly one teaspoon.
According to Dr. Makis, that's where he recommends starting for many cancers.
Can lower doses still have an effect?
✅ He believes they can.
Dr. Makis discusses a published ovarian cancer case reported by Dr. Tess Lawrie.
The dosing chart lists the patient as receiving 12 mg of Ivermectin per day. During his discussion, Dr. Makis explains that this was approximately 0.2 mg/kg/day, placing it within the chart's Low Dose (≤0.5 mg/kg/day) range.
📉 According to the case report, the patient's CA125 tumor marker reportedly fell from 288 to 22 after two months.
That case is one reason Dr. Makis believes Ivermectin may have anticancer activity even at lower doses.
However...
He also believes the available evidence suggests the effect is dose dependent.
In other words...
Higher doses may produce greater effects, although more clinical research is needed.
What about the most aggressive cancers?
• Pancreatic cancer
• Leukemia
• Brain cancer
For cancers like these, Dr. Makis discusses doses around 2 mg/kg/day in selected situations.
He notes that Ivermectin crosses the blood-brain barrier, although not very efficiently, which is one reason he says higher doses may be considered for some brain cancers.
He also discusses a case reported by Dr. Allan Landrito.
According to Dr. Makis, a physician with terminal gallbladder cancer reportedly took 2 mg/kg/day for 14 months.
He says her cancer eventually disappeared.
She experienced temporary visual side effects that resolved after a few days.
❓How high have reported doses gone?
According to Dr. Makis, he has seen reported doses as high as 2.5 mg/kg/day.
He references patients treated by Dr. Shankara Chetty who reportedly used those doses without long-term side effects, although some experienced temporary visual disturbances that later resolved.
One point Dr. Makis returns to repeatedly...
Long-term use.
He references the Castro study involving children with leukemia who reportedly received Ivermectin for six months without long-term side effects.
He also discusses anecdotal reports of adults taking it daily for more than a year without long-term toxicity.
So why aren't there larger cancer trials?
Dr. Makis believes one of the biggest obstacles is economics.
Because Ivermectin is an off-patent generic medicine, he argues there is little financial incentive to fund large clinical trials.
Whether future research ultimately confirms or challenges these ideas remains to be seen.
But Dr. Makis' message is remarkably simple.
One graph.
One dosing strategy.
One starting point.
📌 1 mg/kg/day.
Because the conversation isn't just about Ivermectin anymore.
It's about whether repurposed drugs deserve the same level of scientific investigation as newer therapies.
🗨️ Do you think inexpensive repurposed medicines like Ivermectin deserve larger, well-designed clinical trials for cancer?
🔖 Save this post so you'll always have Dr. Makis' dosing framework handy, and repost it to help others discover the ongoing research into repurposed medicines.
#Ivermectin #CancerResearch #RepurposedDrugs #Oncology #CancerCare #MedicalResearch #PancreaticCancer #MakisMD #RxMeds
🔥🚨Hold onto your cowboy hats for this one. Multiple commercial pilots weigh in, claiming the Earth is completely flat and discussing the "ice wall" theory.
Scientists have grown living human skin on robots with real human DNA...
They can actually bleed and heal...👀
We just gave machines the one thing that makes us human....
Our own DNA..!!🤯
Anthropic just dropped a 100% free course on Loop Engineering with Fable 5.
This is the clearest breakdown of Claude Code and agentic loops you'll find anywhere.
People are paying for tutorials that teach less than this one hour does.
Watch it today, then read the step by step guide on building loops below.
THIS GUY STACKED OVER 50 MAC MINIS ON A RACK AND TURNED THEM INTO A COMPUTE FARM FOR THE PRICE OF ONE GOOD GPU
no cloud provider, no rented gpu cluster, just rows of 599 dollar boxes bolted onto shelves with fans behind them keeping the whole thing cool.
each mini pulls its own job, so instead of one machine waiting in line for tasks, fifty plus run at once and the backlog just disappears.
the real number here is not the 599 dollars per unit, it is what 50 of them cost together against a single enterprise gpu server, and it's not close.
this stopped being a mac mini setup a while ago, it's a server room built out of consumer hardware nobody thought to rack like this.
No Name, No Case 👊💥🔥
This is Jevon Martinez and he may have cracked the code. This is the simplest yet most effective way to prevent the court from acquiring jurisdiction. Listen to how he did it and why it worked.
Wild moment in Yellowstone: A bull bison launched a tourist 8 feet into the air Friday, leaving the visitor seriously injured.
Professional photographer Mike Macleod captured the intense charge on camera, calling the bison “angry, agitated and charging anything and everything.”
Tu hijo vió ese video 3 veces.
Ella ganó $10,000 sin levantarse del sofá.
Mira hasta el 0:25. Ahí es donde muestra lo que salió.
Encuentra una cuenta de niños que quieras replicar. Estudia los formatos. Mira las vistas.
Luego abre Pixar Flow. Pega el prompt. Presiona generar.
Ya está.
Contenido para niños. Millones de vistas por video. Un niño de 3 años ve el mismo dibujo animado hasta que el iPad se sobrecalienta. YouTube cuenta cada repetición. Empuja el video al siguiente niño.
$66/mes en herramientas. Sin rostro. Sin cámara. Sin estudio.
Mes 1, $2,000/mes.
Mes 4, $12,000/mes.
El original tiene millones de vistas. La copia tomó 30 segundos en hacerse.
El algoritmo no sabe la diferencia.
Google CEO, Sundar Pichai:
"If you don't learn to how to orchestrate agents now, you'll spend 2027 catching up to people who started today"
In 30 minutes he explains why the best engineers stopped writing code and started building agents.
Most people think building an agent requires an engineering degree.
It doesn't. It requires one guide and one afternoon.
Watch the interview, then save the exact setup below 👇
Anthropic will pay you $85,000 to learn AI, and this is the kind of opportunity you don't let pass
It's called Claude Corps. Anthropic just launched it, and it's a 12-month paid fellowship for people at the very start of their careers.
They train you to use Claude from scratch, then place you inside a nonprofit to do real work with it for a year. You get paid $85,000 plus benefits the whole time.
They're basically paying you to master the most in-demand skill on the planet right now, then handing you real-world experience using it.
The barrier to entry is almost nothing. Over 18, less than two years of full-time work experience. No degree, no AI background needed.
If that's you, don't sit on this one.
Apply here: https://t.co/qL6r4FFkZ3
Deadline: July 17
Bookmark this